Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision changing from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check8 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA 403 Forbidden error page now appears for the study record, replacing the previous detailed study information and associated documents.SummaryDifference19%

- Check50 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page. This update does not change the study content or data presented.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor backend/content-management update without altering the study’s content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page footer revision label changed from v3.6.3 to v3.6.4, signaling a minor content update to the Study Details page. It does not affect the study information or how the page functions.SummaryDifference0.1%

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.